enzalutamide

enhancer of zeste 2 polycomb repressive complex 2 subunit ; Homo sapiens







6 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35533600 Lycopene enhances the sensitivity of castration-resistant prostate cancer to enzalutamide through the AKT/EZH2/ androgen receptor signaling pathway. 2022 Jul 12 2
2 31085587 Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer. 2019 Jun 21 5
3 31189930 LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling. 2019 Jun 12 1
4 30135193 Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate Cancer. 2018 Oct 15 2
5 27815387 Polycomb-Mediated Disruption of an Androgen Receptor Feedback Loop Drives Castration-Resistant Prostate Cancer. 2017 Jan 15 1
6 28255661 CCN3-EZH2-AR feedback loop: new targets for enzalutamide and castration resistant prostate cancer. 2017 Mar 1